GSK Stockmann expands its expertise in German and European antitrust law, compliance and ESG with new partner Dr Simon Spangler

In another significant strategic move, GSK Stockmann welcomes Simon Spangler as a new partner as of 1 August 2025.

This new addition underlines the firm’s leading position in commercial law and transformation issues and will enhance its range of advisory expertise for national and international clients and projects.

Dr Simon Spangler is a renowned expert in German and European antitrust law as well as in the areas of compliance and ESG. He specialises in providing antitrust and distribution law advice to companies in the technology, consumer goods and life sciences sectors. He also provides comprehensive advice on issues relating to the platform economy, private enforcement issues and merger control proceedings at the national and international level.

In addition, he has many years of experience in related compliance issues, particularly in ESG compliance and internal investigations, as well as in state aid and subsidy law.

Simon Spangler’s wealth of experience and in-depth expertise make him a valuable addition to GSK Stockmann’s Corporate team, where he will work closely with the firm’s IT and AI specialists to set new benchmarks in the field of digital economy and AI solutions and help to accelerate the firm’s growth.

Simon Spangler is joining GSK Stockmann from Oppenhoff & Partner, where he has worked in the field of antitrust and state aid law since 2013, becoming a partner in January 2019. He will be accompanied by his colleague Renée Eckruth, who will join GSK Stockmann as a Senior Associate.

“We are delighted to be welcoming a recognised expert like Simon Spangler to our team. His expertise and network will be a great asset and support the strategic development of our Corporate team. The addition of this new team ensures that we are now in an even stronger position to continue providing our clients with the best possible support with all kinds of complex matters in the future,” says Dr Justus Jansen, Managing Partner at GSK Stockmann.

“Simon Spangler’s impressive range of expertise will be a valuable addition to our Corporate team in Germany, Luxembourg and London. Thanks to his extensive expertise in antitrust law and compliance advice, we can now offer the full scope of services in this area. This enables us to provide real added value to our clients and explore additional areas of advice with significant business development potential. His knowledge and many years of experience will help to strengthen and enhance our Corporate team in the long term,” comments Dr Katy Ritzmann, Head of GSK Stockmann’s Corporate division.

Simon Spangler also sees great potential in his new role at GSK Stockmann: “I am very pleased to be able to put my expertise to good use at GSK Stockmann – especially in dynamic, future-oriented fields such as digitalisation and ESG. Together with the experienced team at GSK Stockmann, I am confident that I can provide our clients with bespoke, forward-thinking advice.”

GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective.

More about us: www.gsk.de